Hot sectors in a tepid recovery
The energy, finance, technology and healthcare industries are expected to be the hottest areas for dealmaking in 2010. Full Article | Full Coverage
Ista sees 2007 gross margin of 70-74 percent
April 26 (Reuters) - Ista Pharmaceuticals Inc. (ISTA.O) on Thursday said it expects its 2007 gross margin of 70 to 74 percent.
In a conference call, the ophthalmic pharmaceutical company said it continues to expect 2007 research and development expense of $24 million to $28 million. (Reporting by Niveditha Ravi in Bangalore)











